| PERIOD ENDING | 29-Aug-09 | 30-May-09 | 28-Feb-09 | 29-Nov-08 | | Total Revenue | 6,321,870 | 6,531,178 | 6,707,567 | 6,468,601 | | Cost of Revenue | 4,633,595 | 4,757,112 | 4,983,847 | 4,743,089 | | | Gross Profit | 1,688,275 | 1,774,066 | 1,723,720 | 1,725,512 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,645,913 | 1,710,672 | 1,739,794 | 1,711,873 | | Non Recurring | 25,557 | 47,035 | 1,873,981 | 140,532 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 16,805 | 16,359 | (1,890,055) | (126,893) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 39,905 | | Earnings Before Interest And Taxes | 16,805 | 16,359 | (1,890,055) | (86,988) | | Interest Expense | 128,828 | 109,478 | 114,207 | 126,615 | | Income Before Tax | (112,023) | (93,119) | (2,004,262) | (213,603) | | Income Tax Expense | 3,989 | 5,327 | 289,396 | 29,522 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (116,012) | (98,446) | (2,293,658) | (243,125) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (116,012) | (98,446) | (2,293,658) | (243,125) | | Preferred Stock And Other Adjustments | (4,364) | (25) | (21,870) | 11,541 | | | Net Income Applicable To Common Shares | ($120,376) | ($98,471) | ($2,315,528) | ($231,584) |
|
0.51% Nasdaq 
0.03 (2.03%) 
Income Statement
